Cybin Doses Last Patient in Part B of Phase 1 DMT Trial

Cybin moves its DMT program forward as it completes dosing of part B of its Phase 1 trial.  See the full press release below. And for a deeper dive into Cybin’s pipeline and trials, see our extended...